US FDA Approves SEROQUEL XR(R) For Add-On Treatment Of Major Depressive Disorder
AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) t...
Medical News Today,
Sat Dec 05 04:41:41 PST 2009
• Found on Yahoo! News
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
WILMINGTON, Del., Dec.
redOrbit,
Fri Dec 04 07:22:50 PST 2009
• Found on Yahoo! News
Topix.net
360,000 news channels, from Autos to your ZIP code.
• Found on Topix News
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
AstraZeneca today announced that the US Food and Drug Administration has approved once-daily SEROQUEL XR® Extended Release Tablets as adjunctive treatment to antidepressants in adults with ...
PR Newswire via Yahoo! Finance,
Fri Dec 04 04:00:00 PST 2009
• Found on Yahoo! News
Significant potential of late- and mid-stage Novartis hematology portfolio to be s...
Novartis announced today that new data, including a late-breaking presentation on Tasigna® 200 mg capsules in a form of chronic myeloid leukemia, demonstrate the strength of the company's h...
PR Newswire via Yahoo! Finance,
Tue Dec 01 22:25:00 PST 2009
• Found on Yahoo! News